At chromatin, SIRT7 catalyzes selectivedeacetylation of lysine 18 on histone H3 (H3K18), an emerging epigenetic biomarker ofaggressive tumors and poor clinical outcome in cancer patients3. This evidence concerns the gene SIRT7 and cancer.